Clinical Trial Update: Disulfiram in Recurrent Glioblastoma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for disulfiram in recurrent glioblastoma, reporting Phase 2 and Phase 3 results; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• Disulfiram (Disulfiram)

Snippet

Sponsor: Sahlgrenska University Hospital | Conditions: Glioma, Glioblastoma | Phase 2, Phase 3 | Status: COMPLETED